|
Federal
Register Notices > Notices
of Registration - 2008 >
Lipomed, Inc
FR Doc E8-12189[Federal Register: June 2, 2008 (Volume 73,
Number 106)] [Notices] [Page 31509-31510] From the Federal
Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02jn08-104]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated March 10, 2008 and published in the Federal
Register on March 19, 2008, (73 FR 14838), Lipomed, Inc., One
Broadway, Cambridge, Massachusetts 02142, made application by
renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of the basic classes of controlled
substances listed in schedule I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
Methaqualone (2565)
|
I
|
|
Gamma Hydroxybutyric Acid (2010)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348)
|
I
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Mescaline (7381)
|
I
|
|
3,4,5-Trimethoxyamphetamine (7390)
|
I
|
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
2,5-Dimethoxy-4-ethylamphetamine (7399)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Dimethyltryptamine (7435)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
Acetyldihydrocodeine (9051)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Heroin (9200)
|
I
|
|
Normorphine (9313)
|
I
|
|
Pholcodine (9314)
|
I
|
|
Tilidine (9750)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage forms) (9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Fentanyl (9801)
|
II
|
|
Sufentanil (9740)
|
II
|
The company plans to import analytical reference standards
for distribution to its customers for research purposes.
No comments or objections have been received. DEA has
considered the factors in 21
U.S.C. 823(a) and 952(a) and
determined that the registration of Lipomed, Inc. to import the
basic classes of controlled substances is consistent with the
public interest and with United States obligations under
international treaties, conventions, or protocols in effect on
May 1, 1971, at this time. DEA has investigated Lipomed, Inc. to
ensure that the company's registration is consistent with the
public interest. The investigation has included inspection and
testing of the company's physical security systems, verification
of the company's compliance with state and local laws, and a
review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with
21 CFR 1301.34, the above named company is granted registration
as an importer of the basic classes of controlled substances
listed.
Dated: May 27, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement Administration.
[FR Doc. E8-12189 Filed 5-30-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
